High Erk-1 activation and Gadd45a expression as prognostic markers in high risk pediatric haemolymphoproliferative diseases

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  D'Angelo, Velia ^a   Crisci, Stefania ^a   Casale, Fiorina ^a   Addeo, Raffaele ^b   Giuliano, Maria ^a   Pota, Elvira ^a   Finsinger, Paola ^a   Baldi, Alfonso ^a   Rondelli, Roberto ^c   Abbruzzese, Alberto ^a   Indolfi, Paolo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b S Giovanni di Dio Hospital   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C JUN; CELL CYCLE PROTEIN; GADD45A PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; NUCLEAR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLAST CELL; BONE MARROW; CELL SURVIVAL; CHILD; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; WESTERN BLOTTING; ADOLESCENT; CLASSIFICATION; INFANT; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROGNOSIS; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; CASPASE 8; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; ENZYME ACTIVATION; FEMALE; HUMANS; INFANT; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHOPROLIFERATIVE DISORDERS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NUCLEAR PROTEINS; PHOSPHORYLATION; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 63849175268     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-39     Document Type: Article

References (24)

1. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. JM Legler LA Ries MA Smith, J Natl Cancer Inst 1999 91 16 1382 90 10.1093/jnci/91.16.1382 10451443
2. Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo. R Addeo F Casale M Caraglia, Cancer Biol Ther 2004 3 5 470 6 15034294
3. P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia. F Casale V D'Angelo R Addeo M Caraglia, Oncol Rep 2004 12 6 1201 7 15547738
4. Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. LS Steelman SL Abrams J Whelan, Leukemia 2008 22 4 686 707 10.1038/leu.2008.26 18337767
5. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest. C Kuntzen N Sonuc E De Toni, Cancer Res 2005 65 15 6780 8 10.1158/0008-5472.CAN-04-2618 16061660
6. ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. C Gregorj MR Ricciardi MT Petrucci, Blood 2007 109 12 5473 6 10.1182/blood-2006-05-021071 17351113
7. Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia. M Milella SM Kornblau Z Estrov, J Clin Invest 2001 108 6 851 9 11560954
8. CR6: A third member in the MyD118 and Gadd45 gene family which functions in negative growth control. W Zhang I Bae K Krishnaraju, Oncogene 1999 18 4899 4907 10.1038/sj.onc.1202885 10490824
9. Hematopoietic cells from Gadd45a- and Gadd45b-deficient mice are sensitized to genotoxic-stress-induced apoptosis. M Gupta SK Gupta AG Balliet, Oncogene 2005 24 7170 7179 10.1038/sj.onc.1208847 16170381
10. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. K Harada S Toyooka N Shivapurkar, Cancer Res 2002 62 20 5897 901 12384554
11. Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia. SM Kornblau M Womble YH Qiu, Blood 2006 108 7 2358 65 16763210 10.1182/blood-2006-02-003475
12. ABL oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectors. MG Kharas DA Fruman, Cancer Res 2005 65 6 2047 53 10.1158/0008-5472.CAN-04-3888 15781610
13. AIEOP Non-B ALL trials. G Masera V Conter Rizzari, Int J Pediatric Hematol Oncol 1999 6 101
14. The morphological classification of acute lymphoblastic leukemia: concordance among observers and clinical correlation. JM Bennet D Catovsky MT Daniel, Br J Haematol 1981 9 6 1012
15. Constitutive ERK1/2 activation in esophagogastric rib bone marrow micrometastatic cells is MEK-independent. OP Barry B Mullan D Sheehan, J Biol Chem 2001 276 15537 15546 10.1074/jbc.M010847200 11297525
16. Association between avB6 integrin expression, elevated p42/44 MAPK, and plasminogen-dependent matrix degradation in ovarian cancer. N Ahmed F Pansino M Baker, J Cell Biochem 2002 84 675 686 10.1002/jcb.10080 11835393
17. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. LS Steelman SC Pohnert JG Shelton, Leukemia 2004 18 2 189 218 10.1038/sj.leu.2403241 14737178
18. An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome. S Kojima M Sako K Kato, Leukemia 2000 14 5 786 91 10.1038/sj.leu.2401754 10803507
19. Disruption of differentiation in human cancer: AML shows the way. DG Tenen, Nat Rev Cancer 2003 3 89 101 10.1038/nrc989 12563308
20. Determination of the in vivo effects of prednisone on Bcl-2 family protein expression in childhood acute lymphoblastic leukemia. F Casale R Addeo V D'Angelo, Int J Oncol 2003 22 1 123 8 12469194
21. Gadd45a and Gadd45b protect hematopoietic cells from UV-induced apoptosis via distinct signaling pathways, including p38 activation and JNK inhibition. M Gupta SK Gupta B Hoffman DA Liebermann, J Biol Chem 2006 281 26 17552 8 10.1074/jbc.M600950200 16636063
22. Changes in apoptosis-related pathways in acute myelocytic leukemia. S Casas J Ollila A Aventín, Cancer Genet Cytogenet 2003 146 2 89 101 10.1016/S0165-4608(03)00102-X 14553942
23. Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia (ALL). R Addeo M Caraglia A Baldi, Cancer Biol Ther 2005 4 1 32 8 15684603
24. Apoptosis-based therapies for hematologic malignancies. JC Reed M Pellecchia, Blood 2005 106 2 408 18 10.1182/blood-2004-07-2761 15797997